Prognostic value of neutrophils in patients with asymptomatic carotid artery disease

Atherosclerosis

Volumn 231, Issue 2, 2013, Pages 274-280

  Mayer, Florian J ^a   Gruenberger, Dieter ^b   Schillinger, Martin ^b   Mannhalter, Christine ^a   Minar, Erich ^b   Koppensteiner, Renate ^b   Arbesú, Itziar ^a   Niessner, Alexander ^a   Hoke, Matthias ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Carotid artery disease; Neutrophils

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAUSE OF DEATH; CELL TYPE; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; NEUTROPHILS;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY;

EID: 84888118250     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.10.002     Document Type: Article

References (40)

1. Mathers C.D., Boerma T., Ma Fat D. Global and regional causes of death. Br Med Bull 2009, 92:7-32.
2. Ross R., Harker L. Hyperlipidemia and atherosclerosis. Science 1976, 193:1094-1100.
3. Cybulsky M.I., Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788-791.
4. Zhou X., Nicoletti A., Elhage R., Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102:2919-2922.
5. Tropea B.I., Huie P., Cooke J.P., Tsao P.S., Sibley R.K., Zarins C.K. Hypertension-enhanced monocyte adhesion in experimental atherosclerosis. JVasc Surg 1996, 23:596-605.
6. Gui T., Shimokado A., Sun Y., Akasaka T., Muragaki Y. Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediators Inflamm 2012, 2012:693083.
7. King V.L., Cassis L.A., Daugherty A. Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice. Am J Pathol 2007, 171:2040-2047.
8. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:2045-2051.
9. Ionita M.G., van den Borne P., Catanzariti L.M., et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol 2010, 30:1842-1848.
10. Naruko T., Ueda M., Haze K., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002, 106:2894-2900.
11. Baetta R., Corsini A. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis 2010, 210:1-13.
12. Soehnlein O., Zernecke A., Weber C. Neutrophils launch monocyte extravasation by release of granule proteins. Thromb Haemost 2009, 102:198-205.
13. Kuller L.H., Tracy R.P., Shaten J., Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996, 144:537-547.
14. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
15. Schillinger M., Exner M., Mlekusch W., et al. Inflammation and carotid artery-risk for atherosclerosis study (ICARAS). Circulation 2005, 111:2203-2209.
16. Iida M., Ikeda F., Ninomiya T., et al. White blood cell count and risk of gastric cancer incidence in a general Japanese population: the Hisayama study. Am J Epidemiol 2012, 175:504-510.
17. Madjid M., Awan I., Willerson J.T., Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. JAm Coll Cardiol 2004, 44:1945-1956.
18. Takeda Y., Suzuki S., Fukutomi T., et al. Elevated white blood cell count as a risk factor of coronary artery disease: inconsistency between forms of the disease. Jpn Heart J 2003, 44:201-211.
19. Sweetnam P.M., Thomas H.F., Yarnell J.W., Baker I.A., Elwood P.C. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 1997, 145:416-421.
20. Gurm H.S., Bhatt D.L., Lincoff A.M., et al. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 2003, 89:1200-1204.
21. Kyne L., Hausdorff J.M., Knight E., Dukas L., Azhar G., Wei J.Y. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 2000, 139:94-100.
22. Haumer M., Amighi J., Exner M., et al. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. JVasc Surg 2005, 41:610-617.
23. Arruda-Olson A.M., Reeder G.S., Bell M.R., Weston S.A., Roger V.L. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcome. 2009, 2:656-662.
24. Toor I.S., Jaumdally R.J., Moss M.S., Babu S.B. Preprocedural neutrophil count predicts outcome in patients with advanced peripheral vascular disease undergoing percutaneous transluminal angioplasty. JVasc Surg 2008, 48:1504-1508.
25. Aoshiba K., Nagai A., Yasui S., Konno K. Nicotine prolongs neutrophil survival by suppressing apoptosis. JLab Clin Med 1996, 127:186-194.
26. Bazzoni G., Dejana E., Del Maschio A. Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 1991, 76:491-499.
27. Fuchs T.A., Brill A., Duerschmied D., et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010, 107:15880-15885.
28. Yipp B.G., Petri B., Salina D., et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking invivo. Nat Med 2012, 18:1386-1393.
29. Demers M., Krause D.S., Schatzberg D., et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A 2012, 109:13076-13081.
30. Nasr N., Ruidavets J.B., Arnal J.F., Sie P., Larrue V. Association of neutrophil count with microembolization in patients with symptomatic carotid artery stenosis. Atherosclerosis 2009, 207:519-523.
31. Kawaguchi H., Mori T., Kawano T., Kono S., Sasaki J., Arakawa K. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J 1996, 132:9-12.
32. Bickel C., Rupprecht H.J., Blankenberg S., et al. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002, 89:901-908.
33. Haim M., Boyko V., Goldbourt U., Battler A., Behar S. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease: the Bezafibrate Infarction Prevention Study. Arch Intern Med 2004, 164:433-439.
34. Papa A., Emdin M., Passino C., Michelassi C., Battaglia D., Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008, 395:27-31.
35. Dragu R., Khoury S., Zuckerman R., et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis 2008, 196:405-412.
36. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004, 109:III39-III43.
37. Owens C.D. Statins and other agents for vascular inflammation. JVasc Surg 2012, 56:1799-1806.
38. Schanzer A., Hevelone N., Owens C.D., Beckman J.A., Belkin M., Conte M.S. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. JVasc Surg 2008, 47:774-781.
39. Ridker P.M., Thuren T., Zalewski A., Libby P. Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J 2011, 162:597-605.
40. Ridker P.M. Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). JThromb Haemost 2009, 7(Suppl.1):332-339.